Head-to-head · WeighScore
AmberHealth vs Pepti
The verdict
AmberHealth takes it — 82.9/100 to 78.8/100.
AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AmberHealth | Pepti |
|---|---|---|
| WeighScore | 82.9/100 | 78.8/100 |
| Grade | B− | C+ |
| Scorecard rank | #25 | #43 |
| Semaglutide | $100/mo | $109 per 28 days (all-in; billing can fall twice in one calendar month) |
| Tirzepatide | $175/mo | $179 per 28 days (all-in; billing can fall twice in one calendar month) |
| Coverage | All 50 states | All 50 states plus Washington, D.C. |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #25 · B−
Strengths
- $100 semaglutide
- All 50 states
- Both molecules
Where it loses points
- Not LegitScript-verified
- Tirzepatide $175
- Monitoring detail sparse
Graded #43 · C+
Strengths
- The figure is stated as the full price with no membership fee, free shipping included, on the product page itself
- Names a medical director by name and board certification, and a second named provider
- Baseline labs are described as included when a clinician requires them, with deeper panels priced openly at $149 and a $129 monthly bloodwork plan
- Coverage is all 50 states and the District of Columbia, stated without a hedge
- Roughly forty prescription peptide products are priced alongside the GLP-1 lines
Where it loses points
- The site prints $79 on its own semaglutide cost page and $109 on the same page, and $149 against $179 for tirzepatide; the figures that transact are $109 and $179
- The product pages label the figure an all-in monthly price while the billing terms set the cycle at 28 days and warn it can bill twice in one calendar month
- An “FDA cleared” badge sits in the homepage trust cluster while the product pages state that compounded medication is neither FDA-approved nor FDA-cleared
- “Our pharmacy partners” names exactly one, Olympia, with no legal entity or address, while the same page says the filling pharmacy varies by patient
- Payment is taken before a physician reviews the intake, and the refund is the remedy
- Labs are conditional rather than included, despite plan copy that reads as though they are standard
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.